An error has occurred while submitting. Please try again later...
Please click below to access whitepaper
Frost & Sullivan: Commercialisation Strategies in Global Biosimilars Industry
An error has occurred while submitting. Please try again later...
Please click below to access whitepaper
Frost & Sullivan: Perspective on Continuous Processing: Trends, Drivers and Strategies
An error has occurred while submitting. Please try again later...
Please click below to access whitepaper
Frost & Sullivan: Cell Therapy Biomanufacturing: Trends and Perspectives
An error has occurred while submitting. Please try again later...
Please click below to access whitepaper
Frost & Sullivan: Enabling Novel Bioprocessing Technologies Using the Interface of Materials Science Biotechnology.
An error has occurred while submitting. Please try again later.
Your form was submitted successfully.
Please click below to access whitepaper
Frost & Sullivan: Transition to Next Gen Downstream Processing to Capitalise on Growth Opportunities in High-Value Low-Volume Biologics
An error has occurred while submitting. Please try again later.
Your form was submitted successfully.
Please click below to access whitepaper
Frost & Sullivan: Perspective on Next Generation Harvest Techniques
An error has occurred while submitting. Please try again later.
Your form was submitted successfully.
Please click below to access whitepaper
Frost & Sullivan: Key Trends Reshaping The Future of Bio-pharmaceutical Harvest and Clarification
An error has occurred while submitting. Please try again later...
Your form was submitted successfully
We understand there’s tremendous pressure to increase speed to clinicals and lower manufacturing costs. Like you, we’re scientists and engineers devoted to increasing the number and availability of life-saving pharmaceuticals. We’ll work with you to optimise your processes, applying our biopharma experience, material science, and proprietary technologies to help you develop highly effective purification solutions.
At 3M, we're advancing the recombinant protein industry by building better, more efficient biopharmaceutical manufacturing processes, developing solutions that allow process compression, and enhanced drug recovery that leads to improved process economics.
3M’s innovative solutions are designed to help develop the manufacturing process for virus-like particles. These remove impurity in harvest & clarification which help maximise downstream purity.
Servicing the plasma fractionation industry for over 30 years, 3M offers a range of products from depth filters, chromatography products, and membrane products, all of which are supported by our validation services offerings.
A wide range of adsorptive depth filters and membrane products for application in the chemical-pharmaceutical industry are available to suit your needs. These products may be used for a range of applications including catalyst removal and recovery, color removal, particulate filtration, and fill-finish.
Get in touch with a 3M Expert for tailored recommendations to transform your filtration processes and resolve challenges. Experience it for yourself with a demonstration and trial data.
Discover insights from industry leaders on the latest trends in bioprocessing. Learn about innovations for optimisation of continuous manufacturing, changes in manufacturing landscapes from biosimilars, and new emerging markets such as cell and gene therapies.
2017 Frost & Sullivan Global Biologics Product Leadership Award. With its next generation technology product, the 3M™ Emphaze™ AEX Hybrid Purifier, 3M demonstrates leadership in meeting specific customer needs.
2018 Minnesota Tekne Biotech/Pharmaceutical Award. MN Tekne Awards celebrate innovation and pioneering efforts in biotechnology or pharmaceuticals to provide game-changing advancement in the healthcare field.